This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
DICE Therapeutics Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for DICE Therapeutics.
Key information
-22.3%
Earnings growth rate
-14.8%
EPS growth rate
| Pharmaceuticals earnings growth | 21.0% |
| Revenue growth rate | 86.8% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 09 Aug 2023 |
Recent future growth updates
Recent updates
We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate
May 14
DICE Therapeutics positive phase 1 data for psoriasis candidate leads shares 71% higher
Oct 11Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation
Sep 11DICE Therapeutics GAAP EPS of -$0.58
Aug 11DICE Therapeutics initiated at buy at Wainwright on platform for small molecule drugs
Jul 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 2 | -224 | -161 | -205 | 8 |
| 12/31/2024 | N/A | -169 | -161 | -155 | 9 |
| 12/31/2023 | N/A | -140 | -116 | -109 | 9 |
| 6/30/2023 | N/A | -104 | -87 | -84 | N/A |
| 3/31/2023 | N/A | -91 | -75 | -73 | N/A |
| 12/31/2022 | N/A | -84 | -67 | -64 | N/A |
| 9/30/2022 | N/A | -77 | -63 | -61 | N/A |
| 6/30/2022 | N/A | -74 | -56 | -54 | N/A |
| 3/31/2022 | 1 | -59 | -46 | -45 | N/A |
| 12/31/2021 | 1 | -49 | -40 | -39 | N/A |
| 9/30/2021 | 1 | -40 | -31 | -30 | N/A |
| 6/30/2021 | 2 | -29 | -27 | -27 | N/A |
| 3/31/2021 | 1 | -27 | -24 | -24 | N/A |
| 12/31/2020 | 1 | -24 | -21 | -21 | N/A |
| 12/31/2019 | 6 | -13 | -17 | -16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DICE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: DICE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: DICE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: DICE is forecast to have no revenue next year.
High Growth Revenue: DICE is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DICE's Return on Equity is forecast to be high in 3 years time